结合性炎症标志物用于预测慢性阻塞性肺部疾病与呼吸系统衰竭中的急性恶化
Xiao-Hua Zhang1,2, Ming-Feng Han2, Xiao-Bao Teng2
1Cheeloo College of Medicine, Shandong University, Jinan, 250000, Shandong, People's Republic of China.
Journal of inflammation research
|February 24, 2025
概括
中性粒细胞-淋巴细胞比率 (NLR),C反应蛋白/白蛋白比率 (CAR) 和血清粉样蛋白A (SAA) 可以预测慢性阻塞性肺病 (AECOPD) 与呼吸衰竭 (RF) 的急性恶化. 这些标记物的联合评估为AECOPD与RF提供了可靠的预测.
科学领域:
- 肺部医学 肺部医学
- 炎症生物标志物 炎症生物标志物
- 关键的护理关键的护理
背景情况:
- 慢性阻塞性肺病 (AECOPD) 的急性恶化可能导致呼吸衰竭 (RF).
- 通过RF确定AECOPD的可靠预测因子对于及时干预和改善患者结果至关重要.
- 系统性炎症在AECOPD的病理生理学中起着重要作用.
研究的目的:
- 评估中性粒细胞-淋巴细胞比率 (NLR),C反应蛋白/白蛋白比率 (CAR) 和血清粉样蛋白A (SAA) 的预测值,用于由RF复杂的AECOPD.
- 评估这些炎症标志物在AECOPD和RF患者的综合预测能力.
- 分析这些标志物与AECOPD患者与RF的一年重收率之间的关联.
主要方法:
- 对198名患有AECOPD的患者进行了回顾性研究.
- 患者被分为两组:带有射频 (n=70) 和没有射频 (n=128).
- 组间基线特征和炎症标志物 (NLR,CAR,SAA) 的比较;用于预测值的ROC曲线分析.
主要成果:
- 患有RF的患者显示白细胞,中性粒细胞,C反应蛋白 (CRP),SAA,NLR和CAR的水平显着更高.
- 在RF群体中,一年内再录取率更高.
- 经过ROC分析,NLR (0.705),CAR (0.659) 和SAA (0.656) 的预测值得出;综合评估得出ROC面积为0.717.
结论:
- NLR,CAR和SAA是与RF一起AECOPD的重要预测因素.
- 对NLR,CAR和SAA的综合评估可靠地反映了AECOPD与RF中的系统性炎症.
- 这些标记物对呼吸衰竭复杂的AECOPD具有预测价值.
相关概念视频
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
01:30Pneumonia III: Complications and Assessment
143
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
143
01:29Acute Respiratory Failure-V
113
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
113
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
41
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
41